Labcorp Clinical Trials is a business segment of Labcorp Inc., a leading global life sciences company, which provides contract research services to the drug, medical device and diagnostics, crop protection and chemical industries. Labcorp is a registered trademark and the marketing name for Labcorp Inc. and its subsidiaries around the world.
Study with 18 total overnights
8425-693 Part B Cohort 3 Part B Cohort 3
Back To Current StudiesStudy with 18 total overnights
Study Number
8425-693 Part B Cohort 3Group
Part B Cohort 3Gender
bothAge
18 - 55Location
Daytona Beach, FloridaCompensation
$9,324Study Dates
Dec. 06 - 30, 2022Additional Information
The purpose of this part of the study is to evaluate the safety, tolerability (side effects), how much of the study drug gets into the bloodstream and urine, and how long it takes the body to get rid of it. This study will also assess the effect of multiple oral doses of the study drug on glycolic acid (a naturally occurring substance found in foods) levels in blood and urine. You will receive an oral dose of the study drug or a placebo (inactive drug) once daily for 14 days. Each group will receive a higher dose than the previous group.
Labcorp Daytona Beach, FL is recruiting for:
- - Healthy Non-Smoking Males and Females of Non-Childbearing Potential, age 18-55
- - Body Mass Index between 18-32
- - Study involves 1 stay of 18 nights, plus 1 additional overnight
- - Compensation up to $9,324 may be provided for time and participation
- - Receive up to $500 per qualified participant
Details
Call to schedule a screening appointment.
Part B Cohort 3
Check-In: Dec 6
Check-Out: Dec 24
Check-In: Dec 29
Check-Out: Dec 30
Calculate Your BMI!
Your Height:
ft / in
Your Weight:
lbs
Select Measurement System:
Your BMI:
result